24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium addresses common and uncommon diagnostic dilemmas encountered within surgical pathology practice. Prior to the symposium, participants will have the opportunity to review clinical...
Multicenter Collaboration Defends against Vector-Borne Diseases - Insights
Teamwork is critical among staff from Mayo Clinic, the Centers for Disease Control and Prevention, Minnesota Department of Health, and the University of Wisconsin-Madison in order to keep tabs on tick trends and defend against vector-borne...
NGS for Myeloid Neoplasm Evaluation - Insights
In this month's "Hot Topic," David Viswanatha, M.D., discusses updates to Mayo Clinic's next-generation sequencing (NGS) for myeloid neoplasm evaluation, involving new test targets, the rationale for new genetic regions, alignments with the...
In this month's "Hot Topic," Brad Karon, M.D., Ph.D., reviews pediatric venipuncture volumes in this year’s Phlebotomy Top Gun case-based presentation as requested by previous Phlebotomy conference attendees.
Applying the Staffing-to-Workload Methodology: Same-Day Testing Staffing Model - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses how to apply the staffing-to-workload methodology to accommodate same-day testing requirements.
MCL - Neurology Specialty Testing Client Test Request - MC0767-02A
MCL - Neurology Specialty Testing Client Test Request
March 2023 - Clinical Biochemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Biochemistry.
Neuro-oncology informative cases - Insights
Clinical studies at the Mayo Clinic have shown that this broad, but tumor-specific, genetic analysis has significant, and sometimes unexpected, clinical impact. The following case studies highlight the importance and clinical utility of...
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.